Part 1: Overview of AHCA/NCAL Clinical Considerations of Antipsychotic Management Toolkit

Size: px
Start display at page:

Download "Part 1: Overview of AHCA/NCAL Clinical Considerations of Antipsychotic Management Toolkit"

Transcription

1 Part 1: Overview of AHCA/NCAL Clinical Considerations of Antipsychotic Management Toolkit Dr. Cathy Lipton, MD Dr. Anna Fisher, PhD Holly Harmon, RN, MBA, LNHA Introduction Holly Harmon 1

2 Objectives Summarize recent regulatory changes and national efforts to reduce antipsychotic use. Understand the key components of the Clinical Considerations of Antipsychotic Management Toolkit and how to encourage use of tools to yield optimal outcomes. Identify a systematic approach for using processes and documents in the Antipsychotic Management Toolkit to manage and/or reduce antipsychotic medication use. Background American Health Care Association (AHCA) & National Center for Assisted Living (NCAL) mission: Improving Lives by Delivering Solutions for Quality Care Clinical Practice Committee Goal: Reduce the use of off-label antipsychotic medications through the promotion and dissemination of existing resources Subcommittee: Antipsychotic Reduction 2

3 Today s Webinar First of a two-part webinar series focused on Antipsychotic Management and Reduction First webinar will include an overview of the issues from a regulatory perspective and an introduction to the AHCA/NCAL clinical toolkit Second webinar will include practical strategies and application of the toolkit to safely reduce antipsychotic use in a resident-centered approach Antipsychotic Use & Initiatives Cathy Lipton 3

4 Off-Label Antipsychotic Use Antipsychotics and other psychotropic medications being used in increasing numbers for behavioral problems in nursing home residents with dementia; limited efficacy and many side effects FDA approved diagnoses for antipsychotic use: Schizophrenia, Huntington s Disease, and Tourette s Syndrome Centers for Medicare and Medicaid Services (CMS) launched a national initiative aimed at improving behavioral health and minimizing the use off-label antipsychotics in nursing homes Adverse Outcomes in Dementia Patients on Antipsychotics Moderate adverse outcomes: tardive dyskinesia, increase in respiratory and urinary tract infections, EPS, delirium Serious adverse outcomes: stroke and related cerebrovascular events Deaths, due to pneumonia, thrombo-embolic events, and sudden cardiac arrhythmias Meta-analysis by FDA showed fold increase in mortality risk for dementia patients on antipsychotics vs. placebo; risk is elevated and persistent with long term usage 4

5 National Partnership to Improve Dementia Care in Nursing Homes On May 30, 2012, Centers for Medicare and Medicaid (CMS) announced the Partnership to Improve Dementia Care, an initiative to ensure appropriate care and use of antipsychotic medications for nursing home residents This partnership consists of federal and state entities, nursing homes and other providers, advocacy groups, and caregivers The initiative was spurred by research showing that one quarter of Medicare beneficiaries in nursing homes are prescribed antipsychotic medications and that the use of these medications may be beneficial but may also be associated with increased risk of death National Partnership to Improve Dementia Care in Nursing Homes Coalition includes: The Centers for Medicare and Medicaid Services Leading Age American Health Quality Association American Health Care Association AMDA The Society for Post-Acute and Long-term Care Medicine 5

6 Partnership to Improve Dementia Care in Nursing Homes Initial goal was a 15% reduction in off-label antipsychotic use in skilled nursing centers between late 2011 and late 2013; this goal was met, with the average reduction just over 17% nationally New goal: additional 10% reduction by the end of 2015 and an additional 5% reduction by the end of 2016, or a total reduction of off-label antipsychotic use of 30% over five years Enhance the use of non-pharmacologic approaches, person-and family-centered dementia care practices, and team-based approaches to dementia care Federal Guidance According to federal guidance, antipsychotics should not be used if the only indication for drug use is one or more of the following issues: Wandering, poor self care, restlessness, impaired memory, anxiety, depression (without psychotic features) Insomnia, unsociability, indifference to surroundings, fidgeting, nervousness, uncooperativeness, or agitated behaviors that do not represent a danger to the resident or others CMS requires attempted gradual dose reductions of the antipsychotic and the use of behavioral interventions (unless clinically contraindicated) 6

7 AHCA/NCAL Quality Initiative Safely Reduce Off-label Use of Antipsychotics For individuals with dementia, and as illness progresses, behavior often becomes a key form of communication. This can be challenging for families and staff, and too often, antipsychotic medication is used in an attempt to modify behavior. The useof antipsychotic medication to treat behavior associated with dementia is not supported clinically and is considered offlabel by the FDA, which issued a black box warning for the elderly with dementia. AHCA/NCAL Quality Initiative Safely Reduce Off-label Use of Antipsychotics Antipsychotic medications are expensive, costing hundreds of millions of Medicare dollars. They also increase the risk of death, falls with fractures, hospitalizations, and other complications resulting in poor health and high costs. The intent of the AHCA/NCAL Quality Initiative goal to safely reduce the off-label use of antipsychotics is to encourage alternative strategies for responding to challenging behavioral expressions in persons living with dementia before considering medications and to ensure that antipsychotic medications, when used, are as appropriate and safe as possible. 7

8 Choosing Wisely Initiative of the American Board of Internal Medicine (ABIM) Five Things Physicians and Patients Should Question American Geriatrics Society: 2 of the 5 Things included antipsychotics and benzodiazepines American Psychiatric Association: ALL 5 of the 5 Things included antipsychotic prescribing American Psychiatric Association s Choosing Wisely Five Things Don t prescribe antipsychotic medications to patients for any indication without appropriate initial evaluation and appropriate ongoing monitoring. Don t routinely prescribe two or more antipsychotic medications concurrently. Don t use antipsychotics as first choice to treat behavioral and psychological symptoms of dementia. Don t routinely prescribe antipsychotic medications as a first-line intervention for insomnia in adults Don t routinely prescribe antipsychotic medications as a first-line intervention for children and adolescents for any diagnosis other than psychotic disorders. 8

9 AHCA/NCAL Toolkit: Clinical Considerations of Antipsychotic Management Anna Fisher Toolkit: Clinical Considerations of Antipsychotic Management Clinically-focused resource with steps, objectives, tools, and expected outcomes Model used is the Nursing, or Care Delivery, Process Multidisciplinary approach Requires center administration investment and leadership Requires input from staff, residents, families, practitioners Seven critical steps needed to ensure quality outcomes that are successful and continuous 9

10 Toolkit Framework: 7 Steps Leadership Recognition/Assessment Diagnosis/Clinical Judgment Outcomes Planning Implementation Evaluation Staff Education Step 1- Leadership Set center direction and goal to better manage antipsychotic drug use and individuals with dementia Ensure staff and others understand what needs to be done and how to accomplish the goal Provide staff education needed to achieve results 10

11 Step 1 - Leadership Hold staff accountable for following care process steps Make regular employee rounds to address questions about the goal Ensure all staff are trained on how to identify unmet needs and nurses are trained on recognizing common antipsychotics Recognize departments and staff doing well in implementing process and using tools Step 2 Recognition/Assessment Timely identification of antipsychotic drug use and behavior, mood, cognition, and function changes Be able to recognize antipsychotic drugs commonly used in the long-term care setting and the issues surrounding the use of these medications Observe resident behaviors Describe behavior/symptom details like onset, intensity, duration, severity to self and/or others 11

12 Step 2 Recognition/Assessment Identify change in level of consciousness (e.g. alert, drowsy, stuporous, comatose) Determine the necessity to control or limit behavior Assess mood, thinking, function, and behavior within 24 hours of admission if an individual is taking an antipsychotic or identified as having a behavior problem For individuals taking antipsychotics, identify where and why treatment started and how effective/problematic the treatment has been Step 3 Diagnosis/Clinical Judgment Use existing medical information and assessment data to form an opinion about probable cause(s) of behavior/symptom Evaluate the current medical regimen as the potential source of behavior/symptom 12

13 Step 4 Outcomes Planning Collect pertinent information as the basis for having identified a specific cause or causes of the problematic behavior/symptom Gather clinical information and diagnoses Include all medications currently taken by the individual Step 4 Outcomes Planning Gather information about drug considered for GDR Current dose, time(s) of drug administration, and method of administration (tablets, capsules, liquid, injectable, IV). How long has the individual been taking this drug? Is the current drug dose at the lowest available dose? If so, does the dose provide the individual optimal quality of life and ADL functioning? Identify the non-pharmacological approaches used to help address challenging behavioral responses. Did these approaches work? Note assessment findings in the medical record. 13

14 Step 5 - Implementation Organize and prepare assessment findings and information to be discussed with the physician Identify specific goals for managing the behavior/symptom After consultation with the physician, document the basis for having identified the problem/symptom(s) and basis for the cause of behavior/symptom Step 6 - Evaluation Monitor responses to interventions for each individual and adjust them accordingly Identify and address complications related to interventions Monitor center frequency of antipsychotic drug use and the effectiveness of strategies 14

15 Step 6 - Evaluation Assess the individual s response to medication discontinuance or tapering. After one month, determine if the individual is at optimal ADL functioning and has an improved quality of life. Repeat any clinical tests and labs ordered by the physician, and evaluate for improvement. Evaluate the effectiveness of non-pharmaceutical approaches to challenging behavioral responses that have been employed, document and change if needed. Step 6 - Evaluation Continue to evaluate and note medication reduction responses in the medical record. Notify the physician about further tapering or drug maintenance as necessary. Monitor for care plan effectiveness. Review each resident s medication regimen for high risk medications and the appropriateness of continued use of any antipsychotic or other psychopharmacological medications. Form a Behavior Management Team to identify unmet needs and monitor and document the effectiveness of interventions. 15

16 Step 7 Staff Education Ensure that staff have the knowledge and skills needed to appropriately provide care to individuals with behavior/symptom(s) Step 7 Staff Education Instruct clinical staff on how to recognize and identify antipsychotic drugs commonly used in the LTC setting Instruct clinical staff on how to apply a systematic approach to collecting, analyzing, documenting, and reporting medical information and clinical findings for potential cause for behavior/symptom Educate all staff in identifying unmet needs 16

17 Key Tools in the Toolkit Physician Guidelines for Gradual Dose Reduction Sample Facility Policy for Use of Antipsychotic Medications Considering Cause of Behavior Algorithm Antipsychotic Medication Tapering Checklist SBAR: Situation, Background, Assessment/Appearance, Request More Key Tools in the Toolkit CHAT: Communicating Health Assessments by Telephone Antipsychotic Medications QA Review Tool Assessment of Residents receiving Psychotropic Medications Tool Common Terms and Definitions Case Studies 17

18 Antipsychotic Prescription Log Antipsychotic Prescription Log Facility Name: Date: Resident Room # Antipsychotic Medication Date antipsychotic medication was started. What setting was the medication started in? Primary mental health diagnosis? Does the resident have dementia? Primary behavioral problems? Does the resident Has GDR have symptoms of been possible drug side attempted? effects? Explain. Date of most recent GDR attempt Outcome of GDR Moving Forward Cathy Lipton 18

19 JAMDA review October 2014 Interventions to Reduce Inappropriate Prescribing of Antipsychotic Medications in People With Dementia Resident in Care Homes: A Systematic Review. JAMDA 15 (2014) Review of 23 articles Education programs, in reach services, medication review, multicomponent interventions Antipsychotic reduction between 12-20% Little information about sustainability and long term reduction Culture and nature of care setting and availability and feasibility of non-drug alternatives Moving Forward CMS is actively seeking input from measurement experts and others on additional measures of person-centered care and dementia care practices in an effort to consider balancing measures, beyond current metrics that quantify antipsychotic medication use. 19

20 Moving Forward CMS and its partners will continue to look at a variety of efforts and interventions to help meet goals, such as: Focused dementia health and safety care surveys Review of surveyor feedback on guidance and trends in enforcement Additional opportunities to measure and publicly report on improved dementia care Continuation of our national education sessions on nonpharmacological, person-centered care Ongoing work of grassroots state coalitions in all 50 states; and Provision of technical assistance through Quality Improvement Organizations (QIOs) or other quality improvement partners Moving Forward CMS will also continue to monitor potential consequences such as: Prescribing shifts from antipsychotic medications to anxiolytics or sedative/hypnotics Changes in functional or cognitive status of nursing home residents that may result from a shift to approaches that do not rely on medication to treat dementia. 20

21 Moving Forward CMS and its partners will continue to promote: Research on improving systems of care in nursing homes Use of individualized, person-centered approaches to care of people with dementia Innovative programs such as telepsychiatry for rural nursing homes The effectiveness of this and other national initiatives to reduce unnecessary antipsychotic medication use in nursing homes Closing Holly Harmon 21

22 Words of Wisdom I did then what I knew how to do. Now that I know better, I do better. Maya Angelou Thank you for improving lives every day! Cathy Lipton: cathy.lipton@optum.com Anna Fisher: fisheranna@ .phoenix.edu Holly Harmon: hharmon@ahca.org 22

23 ahcancal ahcancal Resources Clinical Considerations of Antipsychotic Management Toolkit AHCA/NCAL Toolkit: Members Only Content (login required) This resource uses a process framework, based on the Nursing Process, to identify care objectives and expectations. It identifies tools and resources to help providers successfully manage antipsychotic medication use at the resident and facility level. The guide focuses on seven (7) critical steps needed to ensure quality outcomes that are successful and continuous. Antipsychotic%20Management%20Toolkit.pdf 23

24 Resources The Nursing Process Approach This systematic and evidence-based approach to caring details the steps nurses need to take before contacting the physician to discuss possible gradual dose reduction/tapering for antipsychotics used off-label. The process outlines the information nurses need to collect and analyze in order to make critical decisions about next steps. 0Approach%20for%20Antipsychotic%20Drug%20Gradual%20Dose%20Reduction.pdf The Antipsychotic Medication SBAR This is a tool for nurses to gather and organize the information needed in preparation for physician discussion about potential medication side effects, adverse reactions, and drug tapering. Completed SBARs offer a method to document nurse/physician communication and care plan recommendations and are a component of the individual s medical record. Resources Long Term Care Trend Tracker The LTC Trend Tracker tool, an AHCA member benefit, allows organizations to track and compare their performance on the CMS quality measures, including both long-stay prevalence and short-stay incidence in the offlabel use of antipsychotics. 24

25 Resources The Clinical Considerations of Antipsychotic Management The webinar helps clinicians navigate the toolkit to better manage the clinical factors that contribute to quality care and antipsychotic medication use. Resources A Guide to Reducing Antipsychotic Drugs While Enhancing Care for Persons with Dementia: A Competency-Based Approach This competency-based approach is a guide, filled with resources to increase knowledge, skill, and attitude to address antipsychotic use in your community. CARES Online Training & essentialz Certification AHCA/NCAL offer the CARES Online Dementia Care Training and the Alzheimer s Association essentialz certification program for individuals. 25

26 Resources Reducing the Off-Label Use of Antipsychotics In this webinar, presenters describe a stepwise approach to behavioral management, which can be guided by use of a toolkit developed through a grant funded by the Agency for Healthcare Research and Quality. Advancing Excellence Antipsychotic Resources Advancing Excellence's seven steps to success. Resources AHCA 6-Part Webinar Series: Be Prepared. Don't Let New Surveyor Guidance for F309 Catch You Off-Guard! (member-only content, log-in required) CMS released new surveyor guidance to assess compliance with F309 and F329 as they relate to residents with dementia and use of antipsychotic drugs. AHCA offers a series of six, brief but content-rich webinars to help your community be prepared for these changes. Improving Antipsychotic Appropriateness in Dementia Patients Developed with the support of the Agency for Healthcare Research and Quality, the IA- ADAPT website helps clinicians, providers, and consumers better understand, assess, and address challenging behaviors in people with dementia using evidence-based approaches. It includes user-friendly resources for care providers, as well as information for families or patients on the risks and benefits of antipsychotics for those living with dementia. 26

Psychotropic Drug Use To Medicate or Not to Medicate?

Psychotropic Drug Use To Medicate or Not to Medicate? Psychotropic Drug Use To Medicate or Not to Medicate? Presented by: Lydia Restivo, RN CDONA Regulatory Compliance Consultant West & Restivo Quality Consulting Cell: 516 318-9088 Email: lydrestivo@verizon.net

More information

Improving Resident Care: A look at CMS quality of care initiatives

Improving Resident Care: A look at CMS quality of care initiatives Improving Resident Care: A look at CMS quality of care initiatives W H I T E P A P E R by Diane L. Brown dbrown@hcpro.com What do reduction in rehospitalization, caring for dementia patients and preventing

More information

Nursing Home Pearls or

Nursing Home Pearls or Nursing Home Pearls or How to Enjoy Practicing in Skilled Nursing Facilities Lowell C. Dale, MD November 11, 2016 2016 MFMER slide-1 DISCLOSURE Relevant Financial Relationship Medical Director Golden Living

More information

DEPARTMENT OF HEALTH AND HUMAN SERVICES CENTERS FOR MEDICARE & MEDICAID SERVICES

DEPARTMENT OF HEALTH AND HUMAN SERVICES CENTERS FOR MEDICARE & MEDICAID SERVICES Use for a resident who has potentially unnecessary medications, is prescribed psychotropic medications or has the potential for an adverse outcome to determine whether facility practices are in place to

More information

3/6/2017. CMS nursing home requirements have not been comprehensively updated since 1991 despite significant changes in the industry.

3/6/2017. CMS nursing home requirements have not been comprehensively updated since 1991 despite significant changes in the industry. Debra Brown, PharmD Pharmaceutical Consultant II Specialist Licensing and Certification QCHF/CAHF Spring Legislative Conference March 2017 1 Describe impact of 2016 CMS Final Rule on SNF pharmacy services

More information

Pharmacy Services. Division of Nursing Homes

Pharmacy Services. Division of Nursing Homes Pharmacy Services Division of Nursing Homes 1 483.45 Pharmacy Services Overview The Pharmacy Services section of Appendix PP contains all Pharmacy Services requirements and interpretive guidelines (IG)

More information

Organization: Solution Title: Program/Project Description, including Goals: What is this project? Why is this project important?

Organization: Solution Title: Program/Project Description, including Goals: What is this project? Why is this project important? Organization: Hebrew Home of Greater Washington (The Charles E. Smith Life Communities) The Hebrew Home provides post-acute services and long-term care to a daily average census of 500 residents. The Home

More information

NURSING FACILITY ASSESSMENTS

NURSING FACILITY ASSESSMENTS Department of Health and Human Services OFFICE OF INSPECTOR GENERAL NURSING FACILITY ASSESSMENTS AND CARE PLANS FOR RESIDENTS RECEIVING ATYPICAL ANTIPSYCHOTIC DRUGS Daniel R. Levinson Inspector General

More information

Tip Sheet Reducing Off Label Use of Antipsychotic Medications by Engaging Staff in Individualizing Care to Alleviate Resident Distress

Tip Sheet Reducing Off Label Use of Antipsychotic Medications by Engaging Staff in Individualizing Care to Alleviate Resident Distress Tip Sheet Reducing Off Label Use of Antipsychotic Medications by Engaging Staff in Individualizing Care to Alleviate Resident Distress WHAT IT IS Off label use of antipsychotic medications means uses the

More information

Pain: Facility Assessment Checklists

Pain: Facility Assessment Checklists Pain: Facility Assessment Checklists This is a series of self-assessment checklists for nursing home staff to use to assess processes related to pain management in the facility, in order to identify areas

More information

Antimicrobial Stewardship Program in the Nursing Home

Antimicrobial Stewardship Program in the Nursing Home Antimicrobial Stewardship Program in the Nursing Home CAHF San Bernardino/Riverside Chapter May 19 th, 2016 Presented by Robert Jackson, Pharm.D. Pharmaceutical Consultant II, Specialist CDPH Licensing

More information

The Centers for Medicare & Medicaid Services (CMS) Partnership to Improve Dementia Care

The Centers for Medicare & Medicaid Services (CMS) Partnership to Improve Dementia Care The Centers for Medicare & Medicaid Services (CMS) Partnership to Improve Dementia Care Ohio Psychotropic Medication Nursing Facility Quality Improvement Project Ohio KePRO Nursing Home Quality Care Collaborative

More information

Leveraging Your Facility s 5 Star Analysis to Improve Quality

Leveraging Your Facility s 5 Star Analysis to Improve Quality Leveraging Your Facility s 5 Star Analysis to Improve Quality DNS/DSW Conference November, 2016 Presented by: Kathy Pellatt, Senior Quality Improvement Analyst, LeadingAge NY Susan Chenail, Senior Quality

More information

Pain: Facility Assessment Checklists

Pain: Facility Assessment Checklists Pain: Facility Assessment Checklists A facility system assessment is a starting point for a quality improvement project. The checklists included in this booklet will be most useful if you take a critical

More information

The Department of Justice s Focus on Failure of Care Fraud Cases

The Department of Justice s Focus on Failure of Care Fraud Cases The Department of Justice s Focus on Failure of Care Fraud Cases HCCA 17 TH ANNUAL COMPLIANCE INSTITUTE WASHINGTON, DC APRIL 21, 2013 SUSAN C. LYNCH, ESQ. U.S. DEPARTMENT OF JUSTICE SUSAN.LYNCH@USDOJ.GOV

More information

MDS Coding. Antipsychotic Quality Measure

MDS Coding. Antipsychotic Quality Measure MDS Coding Antipsychotic Quality Measure The information in this presentation may be subject to copyright and may not be reproduced without permission of the presenter. Introduction Jessica Mirabal, RN

More information

OIG Risk Areas: Comprehensive Care Plans, Restorative/Personal Care Services & Medication Management

OIG Risk Areas: Comprehensive Care Plans, Restorative/Personal Care Services & Medication Management OIG Risk Areas: Comprehensive Care Plans, Restorative/Personal Care Services & Medication Management Presented by: Nan Impink, Esq. Kelly Priegnitz, Esq. Harvey Tettlebaum, Esq. Where We ve Been & Today

More information

Improving Dementia Care and Reducing Unnecessary Use of Antipsychotic Medications in Nursing Homes

Improving Dementia Care and Reducing Unnecessary Use of Antipsychotic Medications in Nursing Homes 1 Revision Date: August 2012 SMART AIM Reduce the use of Atypical Anti-Psychotics (AAPs) in Nursing Facilities by 15% by 12/12 KEY DRIVER DIAGRAM - draft Project Name: NF AAP Utilization QI Project Team

More information

Minutes of the Bureau of Health Provider Standards/ Medical Directors Advisory Committee Meeting July 27, 2012

Minutes of the Bureau of Health Provider Standards/ Medical Directors Advisory Committee Meeting July 27, 2012 Minutes of the Bureau of Health Provider Standards/ Medical Directors Advisory Committee Meeting July 27, 2012 ATTENDEES: James Yates, MD, CMD, President Elect Regina Harrell, MD, CMD, Secretary/Treasurer

More information

Core Elements of Antibiotic Stewardship for Nursing Homes

Core Elements of Antibiotic Stewardship for Nursing Homes Core Elements of Antibiotic Stewardship for Nursing Homes Welcome! Holly Harmon, RN, MBA, LNHA Senior Director Clinical Services 1 Leonard Russ Immediate Past Chair AHCA Board of Governors Antibiotic Stewardship

More information

Medication Related Changes Phase 1&2

Medication Related Changes Phase 1&2 Medication Related Changes Phase 1&2 Medicare and Medicaid Programs Reform of Requirements for Long-Term Care Facilities Published January 23, 2017 Medication- Related Changes* Changes will be implemented

More information

Wyoming State Survey Agency

Wyoming State Survey Agency LeadingAge Wyoming September 6, 2018 Wyoming State Survey Agency Laura Hudspeth, MSc, RD, LD, Director Pat Davis, PE, LEED AP, Life Safety and Construction Branch Chief Julia Van Dyke, RN, Healthcare Surveillance

More information

Examining Inappropriate Use of Antipsychotic Drugs Part One: How Seven States Cite Antipsychotic Drug Deficiencies

Examining Inappropriate Use of Antipsychotic Drugs Part One: How Seven States Cite Antipsychotic Drug Deficiencies Examining Inappropriate Use of Antipsychotic Drugs Part One: How Seven States Cite Antipsychotic Drug Deficiencies The misuse of antipsychotic drug is a pervasive problem in American nursing facilities.

More information

POLICY. Use of Antipsychotic Medications in Nursing Facility Residents. Preamble. Background

POLICY. Use of Antipsychotic Medications in Nursing Facility Residents. Preamble. Background Preamble POLICY Use of Antipsychotic Medications in Nursing Facility Residents The Office of Inspector General of the U. S. Department of Health and Human Services issued a report in May 2011 finding that

More information

Nursing Facility Quality Review 2015

Nursing Facility Quality Review 2015 Nursing Facility Quality Review Health and Human Services 6/1/2017 Table of Contents 1. Executive Summary... 1 Findings... 2 Use of Antipsychotic Medications... 2 Measures demonstrating statistically significant

More information

Federal Requirements & Regulatory Provisions Relevant to Dementia Care & The Use Of Antipsychotic Drugs

Federal Requirements & Regulatory Provisions Relevant to Dementia Care & The Use Of Antipsychotic Drugs Federal Requirements & Regulatory Provisions Relevant to Dementia Care & The Use Of Antipsychotic Drugs By: Richard J. Mollot, Executive Director Daniel Butler, Public Policy & Law Intern Long Term Care

More information

Advocates for Long-Term Care Residents Support Regulations to Ensure Independence of LTC Consultant Pharmacists

Advocates for Long-Term Care Residents Support Regulations to Ensure Independence of LTC Consultant Pharmacists Advocates for Long-Term Care Residents Support Regulations to Ensure Independence of LTC Consultant Pharmacists December 12, 2011 Marilyn B. Tavenner Acting Administrator Centers for Medicare & Medicaid

More information

New Quality Measures Will Soon Impact Nursing Home Compare and the 5-Star Rating System: What providers need to know

New Quality Measures Will Soon Impact Nursing Home Compare and the 5-Star Rating System: What providers need to know New Quality Measures Will Soon Impact Nursing Home Compare and the 5-Star Rating System: What providers need to know Presented by: Kathy Pellatt, Senior Quality Improvement Analyst LeadingAge New York

More information

3/14/2014. Preventing Rehospitalizations How to Change Your When in Doubt, Send em Out Way of Thinking. Objectives. Background Information

3/14/2014. Preventing Rehospitalizations How to Change Your When in Doubt, Send em Out Way of Thinking. Objectives. Background Information Preventing Rehospitalizations How to Change Your When in Doubt, Send em Out Way of Thinking Jennifer Moore, RN Content Developer Objectives Describe two reasons why returns to the hospital are not desirable

More information

A Changing Landscape Regulatory Impact on Medication Management

A Changing Landscape Regulatory Impact on Medication Management 2015 Remedi SeniorCare Annual Conference August 30, 2018 A Changing Landscape Regulatory Impact on Medication Management William M. Vaughan RN Vice President, Education / Clinical Affairs Remedi SeniorCare

More information

LTCCC Mid-Term Report to the United Nations UPR on Antipsychotic Drugging in US Nursing Homes

LTCCC Mid-Term Report to the United Nations UPR on Antipsychotic Drugging in US Nursing Homes Mid-Term Report: The Inappropriate Use of Antipsychotic Drugs Among Nursing Home Residents Continues to be Widespread and Immediate Action is Still Needed to Protect Residents from Chemical Restraints

More information

The CMS State Operations Manual Overview and Changes

The CMS State Operations Manual Overview and Changes The CMS State Operations Manual Overview and Changes Omnicare, Inc. Page 1 Overview of the CMS State Operations Manual Executive Summary Historical Perspective The Requirements Pharmacy Services Labeling

More information

What Story Is Your SNF Data Telling?

What Story Is Your SNF Data Telling? What Story Is Your SNF Data Telling? Holly Harmon, RN, MBA, LNHA Senior Director of Clinical Services Thank you to our Launch Sponsor: Objectives Recognize the value of data informed practice Identify

More information

PERFORMANCE MEASURE DATE / RESULTS / ANALYSIS FOLLOW-UP / ACTION PLAN

PERFORMANCE MEASURE DATE / RESULTS / ANALYSIS FOLLOW-UP / ACTION PLAN Resident-to-Resident Assaults AIM: To decrease incidents of Resident to Residents assaults by 5% in the Fiscal Year (FY) 2011-2012. MONITORING: Data is collected from all instances in which State of California

More information

CMS Mega Rule: Implications for Pharmacists and Pharmacies

CMS Mega Rule: Implications for Pharmacists and Pharmacies CMS Mega Rule: Implications for Pharmacists and Pharmacies Curt Wood, RPh, BCGP, FASCP Disclosure and Conflict of Interest Curt Wood declares no conflicts of interest, real or apparent, and no financial

More information

Use of Antipsychotic Medications in Individuals With Alzheimer's Disease in Nursing Facilities

Use of Antipsychotic Medications in Individuals With Alzheimer's Disease in Nursing Facilities Walden University ScholarWorks Walden Dissertations and Doctoral Studies Walden Dissertations and Doctoral Studies Collection 2018 Use of Antipsychotic Medications in Individuals With Alzheimer's Disease

More information

TelePsychiatry in the Long Term Care Setting

TelePsychiatry in the Long Term Care Setting TelePsychiatry in the Long Term Care Setting Presented by: Richard Nockowitz, M.D. Founder & President, My Psychiatric Partner, LLC rnockowitz@mypsychiatricpartner.com Mobile: 614-648-2005 1) What is telepsychiatry?

More information

RNAO Delirium, Dementia, and Depression in Older Adults: Assessment and Care. Recommendation Comparison Chart

RNAO Delirium, Dementia, and Depression in Older Adults: Assessment and Care. Recommendation Comparison Chart RNAO Delirium, Dementia, and Depression in Older Adults: Assessment and Care Recommendation Comparison Chart RECOMMENDATIONS FROM SCREENING FOR DELIRIUM, DEMENTIA AND DEPRESSION IN THE OLDER ADULT (2010)

More information

InformRx. Transition from Hospital to the LTC Facility: Preventing Medication Errors to Reduce Risk of Hospital Readmission

InformRx. Transition from Hospital to the LTC Facility: Preventing Medication Errors to Reduce Risk of Hospital Readmission CLINICAL & REGULATORY NEWS BY PHARMERICA NOV/DEC 2016 Transition from Hospital to the LTC Facility: Preventing Medication Errors to Reduce Risk of Hospital Readmission Transition from the hospital to the

More information

What s Happening in the Nursing Home? Cherry Meier, RN, MSN, NHA Vice President of Public Affairs

What s Happening in the Nursing Home? Cherry Meier, RN, MSN, NHA Vice President of Public Affairs What s Happening in the Nursing Home? Cherry Meier, RN, MSN, NHA Vice President of Public Affairs Objectives Describe the benefits of partnering with hospice Explain the regulations for the interface between

More information

UNDERSTANDING THE NEW MDS 3.0 QUALITY MEASURES

UNDERSTANDING THE NEW MDS 3.0 QUALITY MEASURES UNDERSTANDING THE NEW MDS 3.0 QUALITY MEASURES Updated February 2018 235 Promenade Street, Suite 500, Box 18, Providence, RI 02908 T 401.528.3200 F 401.528.3279 www.healthcarefornewengland.org TABLE OF

More information

Developing and Action Plan: Person Centered Dementia Care and Psychotropic Medications

Developing and Action Plan: Person Centered Dementia Care and Psychotropic Medications Developing and Action Plan: Person Centered Dementia Care and Psychotropic Medications Lisa Bridwell Program Specialist Telligen QIN-QIO March 2018 Objectives Review interpretive guidance F758 (Free from

More information

QAPI: Driving Quality or Just Driving You Crazy

QAPI: Driving Quality or Just Driving You Crazy QAPI: Driving Quality or Just Driving You Crazy Julie Kueker, MBA, MT(ASCP) Nursing Home QIN-QIO Task Lead Objectives Review the Final Rule Changes and Updates for QAPI Describe the format of QAPI methodology

More information

UNDERSTANDING THE NEW MDS 3.0 QUALITY MEASURES

UNDERSTANDING THE NEW MDS 3.0 QUALITY MEASURES UNDERSTANDING THE NEW MDS 3.0 QUALITY MEASURES Updated May 2017 235 Promenade Street, Suite 500, Box 18, Providence, RI 02908 T 401.528.3200 F 401.528.3279 www.healthcarefornewengland.org TABLE OF CONTENTS

More information

The Changing Role of Physicians in LTCF

The Changing Role of Physicians in LTCF The Changing Role of Physicians in LTCF David Gifford MD MPH Boise ID Feb 9 th, 2017 CMS Changes to SNF Regs New rule makes extensive changes to SNF Requirements of Participation (RoP) Last major update

More information

PO Box , Charlotte, NC Phone: (877) Fax: (877)

PO Box , Charlotte, NC Phone: (877) Fax: (877) To apply for help in affording your prescription for Latuda (lurasidone HCl) tablets, please mail or fax a completed application to Sunovion Support Prescription Assistance Program ( Program ), PO Box

More information

Running head: IMPROVING QUALITY OF LIFE 1

Running head: IMPROVING QUALITY OF LIFE 1 Running head: IMPROVING QUALITY OF LIFE 1 Music Therapy: Improving Quality of Life for Dementia Residents in Nursing Homes Keltie P. Keir, B.N., R.N University of New Brunswick IMPROVING QUALITY OF LIFE

More information

Understanding Patient Choice Insights Patient Choice Insights Network

Understanding Patient Choice Insights Patient Choice Insights Network Quality health plans & benefits Healthier living Financial well-being Intelligent solutions Understanding Patient Choice Insights Patient Choice Insights Network SM www.aetna.com Helping consumers gain

More information

Applicant Name Last, First Social Security Number Date of Birth. Applicant s Address City State Zip Code

Applicant Name Last, First Social Security Number Date of Birth. Applicant s Address City State Zip Code MAP-409 COMMONWEALTH OF KENTUCKY DEPARTMENT FOR MEDICAID SERVICES PRE-ADMISSION SCREENING AND RESIDENT REVIEW (PASRR) NURSING FACILITY IDENTIFICATION SCREEN (LEVEL I) Revised March 2007 Applicant Name

More information

HOW WE GOT HERE 1935: Social Security Act Private nursing homes

HOW WE GOT HERE 1935: Social Security Act Private nursing homes 1 LeadingAge Oklahoma Annual Conference March 8, 2017 CMS Revised Pharmacy Regulations: Lessons Learned from Phase 1, Guidance for Phase 2 William M. Vaughan RN, BSN Vice President, Education and Clinical

More information

Understanding the New MDS 3.0 Quality Measures. Updated May 2017

Understanding the New MDS 3.0 Quality Measures. Updated May 2017 Understanding the New MDS 3.0 Quality Measures Updated May 2017 Contents Introduction... 3 Background History of the MDS 3.0:... 3 Percent of Short-Stay Residents Who Self-Report Moderate to Severe Pain...

More information

Notes from CMS Final Rule Document Pertinent to Culture Change and Person-directed Care

Notes from CMS Final Rule Document Pertinent to Culture Change and Person-directed Care Notes from CMS Final Rule Document Pertinent to Culture Change and Person-directed Care Page 594 Prepared by Cathy Lieblich, Director of Network Relations, Pioneer Network G. Benefits of Final Rule: This

More information

Florida Health Care Association 2013 Annual Conference

Florida Health Care Association 2013 Annual Conference Florida Health Care Association 2013 Annual Conference The Westin Diplomat Resort & Spa Session #53 Assess and Educate to Prevent Rehospitalizations Thursday, August 8 10:00 to 11:30 a.m. Regency 1 Upon

More information

Critical Thinking Steps

Critical Thinking Steps CAA s = Critical Thinking CAROL SIEM, MSN, RN, BC, GNP Clinical Educator/Team Leader for QIPMO Critical Thinking Steps Recognition/Assessment Gather essential information about the individual Problem definition

More information

Proposed Accreditation Requirements Related to the Care of Patients or Residents with Dementia

Proposed Accreditation Requirements Related to the Care of Patients or Residents with Dementia Proposed Accreditation Requirements Related to the Care of Patients or Residents with Dementia Nursing and Rehabilitation Center Accreditation Program EC.0001 1 The organization manages safety and security

More information

CMS Announced Changes On Feb 12 th CMS s Open Door Forum conference call

CMS Announced Changes On Feb 12 th CMS s Open Door Forum conference call SUMMARY OF THE CHANGES TO FIVE STAR ANNOUNCED BY CMS Mark Parkinson AHCA/NCAL President & CEO All member call February 13 th, 2015 CMS Announced Changes On Feb 12 th CMS s Open Door Forum conference call

More information

Antibiotics - Are they OVERUSED? 4/6/2018. Antibiotic Stewardship Key Clinical Strategies for Successful Outcomes. Pathway Health 1.

Antibiotics - Are they OVERUSED? 4/6/2018. Antibiotic Stewardship Key Clinical Strategies for Successful Outcomes. Pathway Health 1. Antibiotic Stewardship Key Clinical Strategies for Successful Outcomes Louann Lawson, BA, RN, RAC-CT, CIMT Nurse Consultant Clinical Reimbursement Team Leader/Clinical Education Manager Pathway Health

More information

ROTATION DESCRIPTION

ROTATION DESCRIPTION ROTATION TITLE Psychiatry Pediatrics (PGY2) ROTATION DESCRIPTION PURPOSE The psychiatry rotation is designed to allow the resident to further refine skills in therapeutics, pharmacokinetics, drug information,

More information

DEPARTMENT OF HEALTH AND HUMAN SERVICES CENTERS FOR MEDICARE & MEDICA SERVICES OMB NO. 0938-0391 (X1) PROVER/SUPPLIER/CLIA ENTIFICATION NUMBER: A. BUILDING NAME OF PROVER OR SUPPLIER (X4) 245473 B. WING

More information

TRANSITIONS of CARE. Francis A. Komara, D.O. Michigan State University College of Osteopathic Medicine

TRANSITIONS of CARE. Francis A. Komara, D.O. Michigan State University College of Osteopathic Medicine TRANSITIONS of CARE Francis A. Komara, D.O. Michigan State University College of Osteopathic Medicine 5-15-15 Objectives At the conclusion of the presentation, the participant will be able to: 1. Improve

More information

OBRA 87 & PASRR? Training Goals

OBRA 87 & PASRR? Training Goals Alabama Department of Mental Health Alabama Medicaid Certified Nursing Homes Preadmission Screening & Resident Review (PASRR) for Mental Illness Intellectual Disability & Related Condition Angela Howard

More information

Form CMS (5/2017) Page 1

Form CMS (5/2017) Page 1 Use this pathway for a resident who has pain symptoms or can reasonably be expected to experience pain (i.e., during therapy) to determine whether the facility has provided and the resident has received

More information

INTERACT 4 Patty Abele, FNP BC

INTERACT 4 Patty Abele, FNP BC INTERACT 4 Patty Abele, FNP BC (No relevant financial relationships to disclose) TODAY WE WILL Identify the risks and disadvantages associated with avoidable hospitalizations Identify the goals of the

More information

SUMMARY OF THE CHANGES TO FIVE STAR ANNOUNCED BY CMS. Mark Parkinson AHCA/NCAL President & CEO All member call February 13 th, 2015

SUMMARY OF THE CHANGES TO FIVE STAR ANNOUNCED BY CMS. Mark Parkinson AHCA/NCAL President & CEO All member call February 13 th, 2015 SUMMARY OF THE CHANGES TO FIVE STAR ANNOUNCED BY CMS Mark Parkinson AHCA/NCAL President & CEO All member call February 13 th, 2015 AHCA Requests to CMS Do not go back to a curve Phase in any changes Rebasing

More information

CMS Final Rule Pharmacy Services Update: What You Need to Know!

CMS Final Rule Pharmacy Services Update: What You Need to Know! CMS Final Rule Pharmacy Services Update: What You Need to Know! Presented by: Dr. William C. Hallett, Pharm.D., MBA, CGP, C-MTM Guardian Consulting Services, Inc. (855) 675-6235 whallett@guardianconsulting.com

More information

Contents. Introduction 3. Required knowledge and skills 4. Section One: Knowledge and skills for all nurses and care staff 6

Contents. Introduction 3. Required knowledge and skills 4. Section One: Knowledge and skills for all nurses and care staff 6 Decision-making frameworks in advanced dementia: Links to improved care project. Page 2 of 17 Contents Introduction 3 Required knowledge and skills 4 Section One: Knowledge and skills for all nurses and

More information

SNF REHOSPITALIZATIONS

SNF REHOSPITALIZATIONS SNF REHOSPITALIZATIONS David Gifford MD MPH SVP Quality & Regulatory Affairs National Readmission Summit Arlington VA Dec 6 th, 2013 Use of Long Term Care Services 19% 4 35% 2 20% 1 23% 1 20% 3 1. Mor

More information

Reducing Potentially Avoidable Hospitalizations of Nursing Home Residents

Reducing Potentially Avoidable Hospitalizations of Nursing Home Residents Joseph G. Ouslander, M.D. Professor of Clinical Biomedical Science Associate Dean for Geriatric Programs Charles E. Schmidt College of Biomedical Science Florida Atlantic University Assistant Dean for

More information

Antipsychotic Use Survey Tool Supplemental Guidance

Antipsychotic Use Survey Tool Supplemental Guidance Antipsychotic Use Survey Tool Supplemental Guidance Commonly prescribed antipsychotic medications (brand name and/or generic): First generation (typical) antipsychotic: chlorpromazine (generic only) fluphenazine

More information

Date of Birth: Phone: ( ) Gender: M F. City: State: ZIP:

Date of Birth: Phone: ( ) Gender: M F. City: State: ZIP: To apply for help in affording your LATUDA (lurasidone HCI) prescription, please see Important Safety Information, including Boxed Warning on pages 4 and 5 and enclosed full Prescribing Information. Please

More information

AHCA Requests to CMS

AHCA Requests to CMS SUMMARY OF THE CHANGES TO FIVE STAR ANNOUNCED BY CMS Mark Parkinson AHCA/NCAL President & CEO All member call February 13 th, 2015 AHCA Requests to CMS Do not go back to a curve Phase in any changes Rebasing

More information

Achieving Memory Care Certification for Your Nursing Care Center. Gina Zimmermann, MS Executive Director Nursing Care Center Accreditation Program

Achieving Memory Care Certification for Your Nursing Care Center. Gina Zimmermann, MS Executive Director Nursing Care Center Accreditation Program Copyright, The Joint Commission Achieving Memory Care Certification for Your Nursing Care Center Gina Zimmermann, MS Executive Director Nursing Care Center Accreditation Program 1 Today s Objectives Review

More information

MENTAL HEALTH NURSING ORIENTATION. (2) Alleviating disabling symptoms of mental disorders.

MENTAL HEALTH NURSING ORIENTATION. (2) Alleviating disabling symptoms of mental disorders. Page 1 of 6 1. Mission Statement MENTAL HEALTH NURSING ORIENTATION a. The mission of mental health services is to provide constitutionally adequate care. Mental health care is provided to assist the inmate

More information

CMS RAI MANUAL ERRATA DOCUMENT

CMS RAI MANUAL ERRATA DOCUMENT CMS RAI MANUAL ERRATA DOCUMENT SECTION I UTI S In Chapter 3, page I-9, under Coding Tips in I: Active Diagnoses in the Last 7 Days, a third bullet has been added: If the diagnosis of UTI was made prior

More information

Safe Medication Assistance and Administration Policy

Safe Medication Assistance and Administration Policy Safe Medication Assistance and Administration Policy It is the policy of New Challenges Inc. to provide safe medication setup, assistance and administration: When assigned responsibility in the person

More information

MDS 3.0/RUG IV OVERVIEW

MDS 3.0/RUG IV OVERVIEW MDS 3.0/RUG IV Distance Learning Series January - May 2016 OVERVIEW In keeping with the success of their previous highly-rated distance learning education offerings, LeadingAge state affiliates and Plante

More information

Learning Session 2 for the Ohio Nursing Home Quality Care Collaborative II (NHQCC II) and the Clostridium difficile Infection (CDI) Initiative

Learning Session 2 for the Ohio Nursing Home Quality Care Collaborative II (NHQCC II) and the Clostridium difficile Infection (CDI) Initiative Learning Session 2 for the Ohio Nursing Home Quality Care Collaborative II (NHQCC II) and the Clostridium difficile Infection (CDI) Initiative National Nursing Home Quality Care Collaborative (NNHQCC)

More information

MODULE T. Objectives. Dementia and Alzheimer s Disease. Dementia. N.C. Nurse Aide I Curriculum

MODULE T. Objectives. Dementia and Alzheimer s Disease. Dementia. N.C. Nurse Aide I Curriculum DHSR/HCPR/CARE NAT I Curriculum - July 2013 1 N.C. Nurse Aide I Curriculum MODULE T Disease Objectives Define the terms dementia, Alzheimer s disease, and delirium. Describe the nurse aide s role in the

More information

Patient Centered Care Planning and Behaviors. Presented by: Pam Paulsen, RN/BC,RAC-CT Angela Johnson, PharmD, BCGP

Patient Centered Care Planning and Behaviors. Presented by: Pam Paulsen, RN/BC,RAC-CT Angela Johnson, PharmD, BCGP Patient Centered Care Planning and Behaviors Presented by: Pam Paulsen, RN/BC,RAC-CT Angela Johnson, PharmD, BCGP Objectives 1 2 3 Identify 3 ways to promote patient centered care throughout communication

More information

QAA/QAPI Meeting Agenda Guide

QAA/QAPI Meeting Agenda Guide QAA/QAPI Meeting Agenda Guide Date of Meeting The facility is required to have a QAA committee (do not need to use this name) that meets at least quarterly and as needed to coordinate and evaluate activities

More information

LTC Discharge and Transfer Requirements. Revised October 24, 2017

LTC Discharge and Transfer Requirements. Revised October 24, 2017 LTC Discharge and Transfer Requirements Revised October 24, 2017 OUTLINE Transitions of Care LTC Discharge and Transfer Documentation Requirements Intent of the Regulations TRANSITIONS OF CARE Understanding

More information

Carers Checklist. An outcome measure for people with dementia and their carers. Claire Hodgson Irene Higginson Peter Jefferys

Carers Checklist. An outcome measure for people with dementia and their carers. Claire Hodgson Irene Higginson Peter Jefferys Carers Checklist An outcome measure for people with dementia and their carers Claire Hodgson Irene Higginson Peter Jefferys Contents CARERS CHECKLIST - USER GUIDE 1 OUTCOME ASSESSMENT 1.1 Measuring outcomes

More information

Presenter Disclosure

Presenter Disclosure Improving Transitions from the Hospital to Community Settings IHI National Forum Learning Lab Sunday, December 9, 2012 Session L20 Presenter Disclosure Leora Horwitz, MD Assistant Professor of medicine

More information

Federal Requirements of Participation for Nursing Homes Summary of Key Changes in the Final Rule Issued September 2016 Phase 2

Federal Requirements of Participation for Nursing Homes Summary of Key Changes in the Final Rule Issued September 2016 Phase 2 Federal Requirements of Participation for Nursing Homes Summary of Key Changes in the Final Rule Issued September 2016 Phase 2 On September 28, 2016, the Centers for Medicare & Medicaid Services (CMS)

More information

Re: File Code CMS-4157-FC. Submitted electronically via

Re: File Code CMS-4157-FC. Submitted electronically via P a g e 1 1201 L Street, NW, Washington, DC 20005 Main Telephone: 202-842-4444 Main Fax: 202-842-3860 www.ahca.org Neil Pruitt, Jr. CHAIR UHS-Pruitt Corporation Norcross, GA Leonard Russ VICE CHAIR Bayberry

More information

CMS RULES FOR PARTICIPATION/LTC REGULATIONS: WHAT YOU NEED TO KNOW

CMS RULES FOR PARTICIPATION/LTC REGULATIONS: WHAT YOU NEED TO KNOW CMS RULES FOR PARTICIPATION/LTC REGULATIONS: WHAT YOU NEED TO KNOW SATURDAY/3:15-4:15PM ACPE UAN: 0107-9999-17-242-L04-P 0.1 CEU/1.0 hr Activity Type: Knowledge-Based Learning Objectives for Pharmacists:

More information

THE 2017 QUALIS HEALTH AWARDS OF EXCELLENCE IN HEALTHCARE QUALITY IN WASHINGTON

THE 2017 QUALIS HEALTH AWARDS OF EXCELLENCE IN HEALTHCARE QUALITY IN WASHINGTON THE 2017 QUALIS HEALTH AWARDS OF EXCELLENCE IN HEALTHCARE QUALITY IN WASHINGTON Since 2002, Qualis Health has presented the annual Awards of Excellence in Healthcare Quality to outstanding organizations

More information

Guidelines for Psychotropic Medication Use in Children and Adolescents

Guidelines for Psychotropic Medication Use in Children and Adolescents Guidelines for Psychotropic Medication Use in Children and Adolescents Psychotropic Medication Advisory Committee Department of Children and Families State of Connecticut June 2014 1 Guidelines for Psychotropic

More information

Nursing homes: a case study of prescribing in older people. Carmel M. Hughes

Nursing homes: a case study of prescribing in older people. Carmel M. Hughes Nursing homes: a case study of prescribing in older people Carmel M. Hughes Objectives of lecture To highlight issues with nursing home care, focussing on use of medicines To highlight influences on prescribing

More information

Behavioral Health Services ( )

Behavioral Health Services ( ) Behavioral Health Services ( 483.40) Presenter: Sabine Dettlinger-Metropoulos Summary New Section CMS became aware of concerns that behavioral health services Were either not always being addressed or

More information

Copyrighted - American Society of Consultant Pharmacists - September 29,

Copyrighted - American Society of Consultant Pharmacists - September 29, Practical Tips to Prepare for and Implement the New Pharmacy Sections of the Nursing Home Survey Guidelines Carla Saxton McSpadden, RPh, CGP Assistant Director of Policy and Advocacy American Society of

More information

RAISING THE BAR: IPRO s Medicare Quality Improvement Report for New York State ( )

RAISING THE BAR: IPRO s Medicare Quality Improvement Report for New York State ( ) RAISING THE BAR: IPRO s Medicare Quality Improvement Report for New York State (2011 2014) The Centers for Medicare & Medicaid Services (CMS) leads a national healthcare quality improvement program, which

More information

Effective Tools to Prevent and Manage Adverse Events

Effective Tools to Prevent and Manage Adverse Events Effective Tools to Prevent and Manage Adverse Events Based on Office of Inspector General Adverse Events Report Diane C. Vaughn, RN, C-DONA/LTC; LNHA vaughndiane@hotmail.com Objectives Upon completion

More information

Using Clinical Criteria for Evaluating Short Stays and Beyond. Georgeann Edford, RN, MBA, CCS-P. The Clinical Face of Medical Necessity

Using Clinical Criteria for Evaluating Short Stays and Beyond. Georgeann Edford, RN, MBA, CCS-P. The Clinical Face of Medical Necessity Using Clinical Criteria for Evaluating Short Stays and Beyond Georgeann Edford, RN, MBA, CCS-P The Clinical Face of Medical Necessity 1 The Documentation Faces of Medical Necessity ç3 Setting the Stage

More information

Adult Family Homes. Susan L. Lakey, PharmD Pharmacy 492 January 24, 2005

Adult Family Homes. Susan L. Lakey, PharmD Pharmacy 492 January 24, 2005 Adult Family Homes Susan L. Lakey, PharmD Pharmacy 492 January 24, 2005 Background 1995 HB 1908 Required a reduction in NH medicaid beds by 1600 over 2 years The number of older adults in nursing homes

More information

Session #: R14. Robin L. Hillier. Agenda 4/9/2014. Simply Quality Measures. (330) RLH Consulting.

Session #: R14. Robin L. Hillier. Agenda 4/9/2014. Simply Quality Measures. (330) RLH Consulting. Session #: R14 Simply Quality Measures Robin L. Hillier robin@rlh-consulting.com (330) 807-2850 RLH Consulting Agenda Quality Measures How are they calculated How to read the reports How to use the reports

More information

An Overview of the new LTCF Requirements of Participation: Are You Ready?

An Overview of the new LTCF Requirements of Participation: Are You Ready? An Overview of the new LTCF Requirements of Participation: Are You Ready? David Gifford MD MPH Sr VP for Quality & Regulatory Affairs Feb 9 th 2017 3:15 pm 4:45 pm Boise ID CMS Changes to SNF Regs New

More information

Payment Reforms to Improve Care for Patients with Serious Illness

Payment Reforms to Improve Care for Patients with Serious Illness Payment Reforms to Improve Care for Patients with Serious Illness Discussion Draft March 2017 Payment Reforms to Improve Care for Patients with Serious Illness Page 2 PAYMENT REFORMS TO IMPROVE CARE FOR

More information

Transitions of Care: From Hospital to Home

Transitions of Care: From Hospital to Home Transitions of Care: From Hospital to Home Danielle Hansen, DO, MS (Med Ed) Associate Director, LECOM VP Acute Care Services & Quality/Performance Improvement, Millcreek Community Hospital Objectives Discuss

More information

Caregivers of Adults with Severe Mental Illness: Results of a National Study

Caregivers of Adults with Severe Mental Illness: Results of a National Study Caregivers of Adults with Severe Mental Illness: Results of a National Study Gail Hunt, President & CEO National Alliance for Caregiving Angela Kimball, National Director of Advocacy & Public Policy National

More information